Aspira Women's Health Inc.
AWHL· OTC
Released Aug 10, 2016, during market hours
10-Q filed Aug 10, 2016, 41 days after period end · 0000926617-16-000098
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $709.00K | $535.00K | $324.00K | $323.00K |
| Net Income | -$3.75M | -$4.85M | -$5.56M | -$2.12M |
| EPS Diluted | -$0.07 |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.11 |
| -$0.15 |
| -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.